Inari Medical, Inc. (NARI)
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Investigation
08/10/2021
Initial Lawsuit
08/27/2021
Lawsuit Progression
11/19/2021
Did HyreCar mislead investors about its insurance reserves, paid valid claims, profitability, and the direct costs v. good retention ratio of its insurance business?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We update this post regularly.
08/10/2021
HyreCar releases its Q2 2021 financial results, including net losses of $9.3 million compared to losses of $3.8 million in the same period the prior year. Adjusted EBITDA loss for Q2 2021 of $7.1 million, four times higher than the $1.7 million adjusted EBITDA loss experienced in the second quarter of 2020. Gross profit for Q2 2021 of just $0.8 million, less than one third the Company’s gross profit in the second quarter of 2020.
The company also discloses it incurred high costs of revenue during the quarter primarily as a result of significantly higher insurance claims incidence – including claims before March 31, 2021.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$9.85 | $19.12 | $-9.27 | -48.48% |
A HyreCar, Inc. (HYRE) investor filed a securities class action lawsuit on behalf of all purchasers of HyreCar securities between May 14, 2021, and August 10, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(a) that HyreCar had materially understated its insurance reserves;
(b) that HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period;
(c) that HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods;
(d) that HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result;
(e) that HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and
(f) that, as a result of (a)-(e) above, HyreCar’s operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar’s purported gross margin, EBITDA and net loss trajectories.
11/19/2021
The court issued an order appointing the lead plaintiff and lead counsel.
12/03/2021
This is a securities class action on behalf of all purchasers of HyreCar securities between February 3, 2021 and August 17, 2021, inclusive.
Additional amended complaints have been filed, please refer to the last filed amended complaint for up-to-date information.
03/21/2022
This is a securities class action on behalf of all purchasers of HyreCar securities between May 13, 2021 and August 10, 2021, inclusive.
Operative complaint
04/04/2022
A motion to dismiss was filed with the court.
02/16/2022
Court Granted the motion to dismiss.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.